Replication-selective Oncolytic Adenovirus CNHK300 in the Treatment of Breast Cancer Cell Lines in vitro

[1]  B. Murphy,et al.  Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity , 2004, Cancer Gene Therapy.

[2]  S. Woo,et al.  Telomerase-dependent oncolytic adenovirus for cancer treatment , 2003, Gene Therapy.

[3]  M. Manns,et al.  A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer. , 2003, Cancer research.

[4]  C. Ring.  Cytolytic viruses as potential anti-cancer agents. , 2002, The Journal of general virology.

[5]  J. Lebkowski,et al.  The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters , 2001, Gene Therapy.

[6]  J. Gu,et al.  Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers. , 2000, Cancer research.

[7]  D. Brough,et al.  Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen. , 2000, The Journal of clinical investigation.

[8]  S. Kyo,et al.  A novel telomerase-specific gene therapy: gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter. , 2000, Human gene therapy.

[9]  C. Balagué,et al.  Replicative adenoviruses for cancer therapy , 2000, Nature Biotechnology.

[10]  Y. Chiang,et al.  A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma. , 1999, Human gene therapy.

[11]  J. Simons,et al.  Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. , 1997, Cancer research.

[12]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[13]  A. Fattaey,et al.  An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells , 1996, Science.

[14]  et al.,et al.  The RNA component of human telomerase , 1995, Science.